Park Medi World Ltd has spent ₹702.30 crore of the funds raised through its Initial Public Offering (IPO), according to a report by CRISIL. This capital was allocated towards significant debt repayment, capital expenditure for new hospital construction, and strategic acquisitions.
However, ₹67.70 crore of the IPO proceeds remains unutilized as of March 31, 2026. The primary reason cited for this unspent portion is delays encountered in procuring essential medical equipment. Specifically, delays in acquiring equipment for FY26, estimated at ₹229.59 million, pose a risk to project timelines.
The IPO originally raised ₹7,700 million (₹770 crore) in gross proceeds, with net proceeds totaling ₹7,132.77 million (₹713.27 crore) after deducting offering expenses. Of the net proceeds, ₹7,023.02 million has been utilized, leaving ₹676.98 million unspent. Investors will be closely watching Park Medi World's ability to resolve procurement delays and deploy the remaining capital effectively to meet its expansion goals.
Leading hospital chains such as Apollo Hospitals, Fortis Healthcare, and Max Healthcare are also actively investing in expansion and technology. These peers frequently undertake capital expenditure for new facilities and pursue strategic acquisitions to strengthen their market positions.